Search

Adam M Marcetich

Examiner (ID: 16473, Phone: (571)272-2590 , Office: P/3761 )

Most Active Art Unit
3761
Art Unit(s)
3781, 3761
Total Applications
1415
Issued Applications
890
Pending Applications
99
Abandoned Applications
426

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 2889904 [patent_doc_number] => 05240695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-31 [patent_title] => 'Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound' [patent_app_type] => 1 [patent_app_number] => 7/962676 [patent_app_country] => US [patent_app_date] => 1992-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3076 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/240/05240695.pdf [firstpage_image] =>[orig_patent_app_number] => 962676 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/962676
Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound Oct 18, 1992 Issued
07/961061 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-BETA FOR BONE REPAIR Oct 13, 1992 Abandoned
07/960199 AGENT FOR TREATING OR PREVENTING AIDS Oct 8, 1992 Abandoned
Array ( [id] => 3458449 [patent_doc_number] => 05401832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Brain derived and recombinant acidic fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 7/951365 [patent_app_country] => US [patent_app_date] => 1992-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12240 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401832.pdf [firstpage_image] =>[orig_patent_app_number] => 951365 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/951365
Brain derived and recombinant acidic fibroblast growth factor Sep 24, 1992 Issued
07/934722 CURCULIN C Aug 23, 1992 Abandoned
Array ( [id] => 3034605 [patent_doc_number] => 05300490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-05 [patent_title] => 'Anticoagulant substance obtained from urine' [patent_app_type] => 1 [patent_app_number] => 7/932559 [patent_app_country] => US [patent_app_date] => 1992-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6157 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/300/05300490.pdf [firstpage_image] =>[orig_patent_app_number] => 932559 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/932559
Anticoagulant substance obtained from urine Aug 19, 1992 Issued
07/932134 METHOD FOR INHIBITING HIV REPLICATION USING IL-4 Aug 18, 1992 Abandoned
Array ( [id] => 3076284 [patent_doc_number] => 05322837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-21 [patent_title] => 'Homogeneous erythropoietin compositions and methods of using same' [patent_app_type] => 1 [patent_app_number] => 7/903220 [patent_app_country] => US [patent_app_date] => 1992-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4375 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/322/05322837.pdf [firstpage_image] =>[orig_patent_app_number] => 903220 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/903220
Homogeneous erythropoietin compositions and methods of using same Jul 30, 1992 Issued
Array ( [id] => 3490046 [patent_doc_number] => 05439884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'Method of controlling fertilization using bombesin or its agonist' [patent_app_type] => 1 [patent_app_number] => 7/919731 [patent_app_country] => US [patent_app_date] => 1992-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10177 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/439/05439884.pdf [firstpage_image] =>[orig_patent_app_number] => 919731 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/919731
Method of controlling fertilization using bombesin or its agonist Jul 26, 1992 Issued
Array ( [id] => 3425790 [patent_doc_number] => 05416071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-16 [patent_title] => 'Water-soluble composition for sustained-release containing epo and hyaluronic acid' [patent_app_type] => 1 [patent_app_number] => 7/909160 [patent_app_country] => US [patent_app_date] => 1992-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19713 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/416/05416071.pdf [firstpage_image] =>[orig_patent_app_number] => 909160 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/909160
Water-soluble composition for sustained-release containing epo and hyaluronic acid Jul 5, 1992 Issued
Array ( [id] => 2952656 [patent_doc_number] => 05231010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-27 [patent_title] => 'Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof' [patent_app_type] => 1 [patent_app_number] => 7/904246 [patent_app_country] => US [patent_app_date] => 1992-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4592 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/231/05231010.pdf [firstpage_image] =>[orig_patent_app_number] => 904246 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/904246
Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof Jun 24, 1992 Issued
Array ( [id] => 3007092 [patent_doc_number] => 05374713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites' [patent_app_type] => 1 [patent_app_number] => 7/861962 [patent_app_country] => US [patent_app_date] => 1992-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1450 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374713.pdf [firstpage_image] =>[orig_patent_app_number] => 861962 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/861962
Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites Jun 17, 1992 Issued
07/897135 PROPHYLAXIS AND TREATMENT OF COAGULATION DISORDERS ASSOCIATED WITH SEPTICEMIA Jun 10, 1992 Abandoned
Array ( [id] => 3459794 [patent_doc_number] => 05382574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-17 [patent_title] => 'Insulin preparations containing nicotinic acid or nicotinamide' [patent_app_type] => 1 [patent_app_number] => 7/849448 [patent_app_country] => US [patent_app_date] => 1992-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2612 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/382/05382574.pdf [firstpage_image] =>[orig_patent_app_number] => 849448 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/849448
Insulin preparations containing nicotinic acid or nicotinamide May 19, 1992 Issued
Array ( [id] => 2881014 [patent_doc_number] => 05268169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-07 [patent_title] => 'Treatment method of ovarian cancer using interferon gamma' [patent_app_type] => 1 [patent_app_number] => 7/867778 [patent_app_country] => US [patent_app_date] => 1992-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1276 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/268/05268169.pdf [firstpage_image] =>[orig_patent_app_number] => 867778 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/867778
Treatment method of ovarian cancer using interferon gamma Apr 12, 1992 Issued
Array ( [id] => 2919344 [patent_doc_number] => 05234908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Method of treating gastrointestinal ulcers with platelet derived growth factor' [patent_app_type] => 1 [patent_app_number] => 7/866822 [patent_app_country] => US [patent_app_date] => 1992-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4535 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234908.pdf [firstpage_image] =>[orig_patent_app_number] => 866822 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/866822
Method of treating gastrointestinal ulcers with platelet derived growth factor Apr 9, 1992 Issued
07/863251 PHARMACEUTICAL COMPOSITION OF STABILIZED [LEU 1 3]-MOTILIN-HSE Apr 2, 1992 Abandoned
Array ( [id] => 2976070 [patent_doc_number] => 05256644 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Wound healing using IGF-II and TGF' [patent_app_type] => 1 [patent_app_number] => 7/857713 [patent_app_country] => US [patent_app_date] => 1992-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2715 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256644.pdf [firstpage_image] =>[orig_patent_app_number] => 857713 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/857713
Wound healing using IGF-II and TGF Mar 24, 1992 Issued
Array ( [id] => 3039846 [patent_doc_number] => 05376636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-27 [patent_title] => 'Method for promoting tissue repair and regeneration using PDGF and glucocorticoids' [patent_app_type] => 1 [patent_app_number] => 7/849931 [patent_app_country] => US [patent_app_date] => 1992-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3525 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/376/05376636.pdf [firstpage_image] =>[orig_patent_app_number] => 849931 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/849931
Method for promoting tissue repair and regeneration using PDGF and glucocorticoids Mar 11, 1992 Issued
Array ( [id] => 2970862 [patent_doc_number] => 05258501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-02 [patent_title] => 'Stabilization of glycoproteins' [patent_app_type] => 1 [patent_app_number] => 7/844826 [patent_app_country] => US [patent_app_date] => 1992-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6183 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/258/05258501.pdf [firstpage_image] =>[orig_patent_app_number] => 844826 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/844826
Stabilization of glycoproteins Mar 1, 1992 Issued
Menu